Výsledky vyhledávání - "Sophie E M Veldhuijzen van Zanten"

Akademický článek

Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners

Autor: Yulun Wu, Tobias C. Wood, Sophie H. A. E. Derks, Ilanah J. Pruis, Sebastian van der Voort, Sophie E. M. Veldhuijzen van Zanten, Marion Smits, Esther A. H. Warnert

Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)

Abstract Amide proton transfer (APT)-weighted chemical exchange saturation transfer (CEST) imaging is a recent MRI technique making its way into clinical application. In this work, we investigated whether APT-weighted CEST imaging can provide reprodu

Externí odkaz: https://doaj.org/article/1e57fac330164976bb550f6f78e81dc5

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances

Autor: Sophie E. M. Veldhuijzen van Zanten, Kay J. Pieterman, Bas P. L. Wijnhoven, Ilanah J. Pruis, Bas Groot Koerkamp, Lydi M. J. W. van Driel, Frederik A. Verburg, Maarten G. J. Thomeer

Publikováno v: Diagnostics, Vol 12, Iss 8, p 1958 (2022)

Introduction: There is a pressing demand for the development of cancer-specific diagnostic imaging tools, particularly for staging of pancreatic-, gastric- or cholangiocarcinoma, as current diagnostic imaging techniques, including CT, MRI and PET usi

Externí odkaz: https://doaj.org/article/604fade24b3242dc84f113398409c73d

Zobrazit plný text záznamu

Akademický článek

Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates

Autor: Fatma E. El-Khouly, Dannis G. van Vuurden, Thom Stroink, Esther Hulleman, Gertjan J. L. Kaspers, N. Harry Hendrikse, Sophie E. M. Veldhuijzen van Zanten

Publikováno v: Frontiers in Oncology, Vol 7 (2017)

Despite decades of clinical trials for diffuse intrinsic pontine glioma (DIPG), patient survival does not exceed 10% at two years post-diagnosis. Lack of benefit from systemic chemotherapy may be attributed to an intact bloodbrain barrier (BBB). We a

Externí odkaz: https://doaj.org/article/4a322cdbe4634fe9a7b23ba068755009

Zobrazit plný text záznamu

Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates

Publikováno v: Neuro-Oncology Advances, 4(1):vdac077. Oxford University Press
Gielen, G H, Baugh, J N, van Vuurden, D G, Veldhuijzen van Zanten, S E M, Hargrave, D, Massimino, M, Biassoni, V, Morales la Madrid, A, Karremann, M, Wiese, M, Thomale, U, Janssens, G O, von Bueren, A O, Perwein, T, Nussbaumer, G, Hoving, E W, Niehusmann, P, Gessi, M, Kwiecien, R, Bailey, S, Pietsch, T, Andreiuolo, F & Kramm, C M 2022, ' Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates ', Neuro-oncology advances, vol. 4, no. 1, vdac077 . https://doi.org/10.1093/noajnl/vdac077
Neuro-oncology advances, 4(1):vdac077. Oxford University Press

Background The WHO Classification of Tumors of the Central Nervous System has undergone major restructuring. Molecularly defined diagnostic criteria were introduced in 2016 (revised 4th edition) and expanded in 2021 (5th edition) to incorporate furth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a6339ea9078d2302d8796158d8a57a9
https://pubmed.ncbi.nlm.nih.gov/35733513

Zobrazit plný text záznamu

Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters

Autor: Ilanah J Pruis, Stephan R Koene, Sebastian R van der Voort, Fatih Incekara, Arnaud J P E Vincent, Martin J van den Bent, Geert J Lycklama à Nijeholt, Rishi D S Nandoe Tewarie, Sophie E M Veldhuijzen van Zanten, Marion Smits

Publikováno v: Neuro-Oncology Advances, 4(1):vdac023. Oxford University Press
Pruis, I J, Koene, S R, van der Voort, S R, Incekara, F, Vincent, A J P E, van den Bent, M J, Lycklama À Nijeholt, G J, Nandoe Tewarie, R D S, Veldhuijzen van Zanten, S E M & Smits, M 2022, ' Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters ', Neuro-oncology advances, vol. 4, no. 1, vdac023 . https://doi.org/10.1093/noajnl/vdac023
Neuro-oncology advances, 4(1):vdac023. Oxford University Press

Background Nonenhancing glioma typically have a favorable outcome, but approximately 19–44% have a highly aggressive course due to a glioblastoma genetic profile. The aim of this retrospective study is to use physiological MRI parameters of both pe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ab430fc894c126437a4d20ba33b1d57
http://www.scopus.com/inward/record.url?scp=85134975367&partnerID=8YFLogxK

Zobrazit plný text záznamu

HGG-49. Gliomatosis cerebri in children: A collaborative report from the European Society for Pediatric Oncology (SIOPE)

Autor: Gunther Nussbaumer, Martin Benesch, Gerrit H Gielen, David Castel, Jacques Grill, Marta M Alonso Roldán, Manila Antonelli, Simon Bailey, Joshua N Baugh, Veronica Biassoni, Andrea Carai, Niclas Colditz, Giovanni Stefania Colefati, Selim Corbacioglu, Shauna Crampsie, Natacha Entz-Werle, Matthias Eyrich, Michael C Frühwald, Maria Luisa Garrè, Nicolas U Gerber, Felice Giangaspero, Maria João Gil-da-Costa, Yura Grabovska, Norbert Graf, Darren Hargrave, Peter Hauser, Marion Hoffmann, Esther Hulleman, Sandra Jacobs, Michael Karremann, Antonis Kattamis, Rejin Kebudi, Rolf-Dieter Kortmann, Robert Kwiecien, Alan Mackay, Maura Massimino, Evelina Miele, Angela Mastronuzzi, Giovanni Morana, Claudia M Noack, Virve Pentikainen, Thomas Perwein, Stefan M Pfister, Torsten Pietsch, Kleoniki Roka, Sabrina Rossi, Stefan Rutkowski, Elisabetta Schiavello, Jaroslav Štěrba, Dominik Sturm, David Sumerauer, Sara Temelso, Dannis van Vuurden, Pascale Varlet, Sophie E M Veldhuijzen van Zanten, Maria Vinci, André O von Bueren, Monika Warmuth-Metz, Pieter Wesseling, Maria Wiese, Johannes E A Wolff, Josef Zamecnik, David T W Jones, Brigitte Bison, Andrés Morales La Madrid, Chris Jones, Christof M Kramm

Publikováno v: Neuro-Oncology. 24:i72-i73

BACKGROUND: Gliomatosis cerebri (GC), a radiologically defined diffusely infiltrating glioma, is no longer considered a distinct entity since the 2016 WHO classification for tumors of the CNS. Due to its rarity and dismal prognosis treatment recommen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::61e998beb8006a1b4e7da011e2210a27
https://doi.org/10.1093/neuonc/noac079.264

Zobrazit plný text záznamu

Complementary and alternative medicine in children with diffuse intrinsic pontine glioma—A SIOPE DIPG Network and Registry study

Autor: Syed M Adil, Maria Wiese, N. Harry Hendrikse, Esther Hulleman, Christof M. Kramm, Gertjan J.L. Kaspers, Sophie E. M. Veldhuijzen van Zanten, Dannis G. van Vuurden, Fatma E El-Khouly

Publikováno v: Pediatric Blood and Cancer, 68(9):e29061. Wiley-Liss Inc.
el-Khouly, F E, Adil, S M, Wiese, M, Hulleman, E, Hendrikse, N H, Kaspers, G J L, Kramm, C M, SIOPE DIPG Network, Veldhuijzen van Zanten, S E M & van Vuurden, D G 2021, ' Complementary and alternative medicine in children with diffuse intrinsic pontine glioma—A SIOPE DIPG Network and Registry study ', Pediatric Blood and Cancer, vol. 68, no. 9, e29061 . https://doi.org/10.1002/pbc.29061

Introduction: Diffuse intrinsic pontine glioma (DIPG) is a rare and aggressive childhood brainstem malignancy with a 2-year survival rate of 2= 6.08, p =.014). No significant difference was found between CAM users and nonusers based on ethnicity (χ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d36b5f092d3cf1fd799e49b0aeb0e45
https://doi.org/10.1002/pbc.29061

Zobrazit plný text záznamu

A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma

Autor: Fatma E El-Khouly, Sophie E. M. Veldhuijzen van Zanten, Esther Sanchez Aliaga, W. Peter Vandertop, Dannis G. van Vuurden, N. Harry Hendrikse, Dewi P. Bakker, Gertjan J.L. Kaspers, Marc H. A. Jansen

Publikováno v: Journal of Neuro-Oncology, 153(2), 263-271. Kluwer Academic Publishers
Journal of Neuro-Oncology, 153(2), 263-271. Kluwer Academic
Journal of neuro-oncology, 153(2), 263-271. Kluwer Academic Publishers
Journal of Neuro-Oncology
El-Khouly, F E, Veldhuijzen van Zanten, S E M, Jansen, M H A, Bakker, D P, Sanchez Aliaga, E, Hendrikse, N H, Vandertop, W P, van Vuurden, D G & Kaspers, G J L 2021, ' A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma ', Journal of Neuro-Oncology, vol. 153, no. 2, pp. 263-271 . https://doi.org/10.1007/s11060-021-03763-1

Introduction This study investigates the safety, tolerability, and preliminary efficacy of combined treatment with VEGF inhibitor bevacizumab, topoisomerase I inhibitor irinotecan, and EGFR inhibitor erlotinib in children with progressive diffuse int

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5cd964c19a4c2c73e81b5e280ec0d5
https://research.vumc.nl/en/publications/99c311f6-a6ec-4c49-9b55-1e02e59d3bb6

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání